Abstract
Diffuse Large B-Cell Lymphoma (DLBCL) Patients with Late Relapses Who Are Transplant-Eligible Have Excellent Outcomes and May Represent Unique Biology
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have